Actively Recruiting
Find HDV and Determine Its Status in Turkey
Led by Yaşar Bayındır, MD · Updated on 2024-08-12
20000
Participants Needed
2
Research Sites
50 weeks
Total Duration
On this page
Sponsors
Y
Yaşar Bayındır, MD
Lead Sponsor
S
SOUTHEAST NEUROLOGY AND INFECTIOUS DISEASES SOCIETY
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.
CONDITIONS
Official Title
Find HDV and Determine Its Status in Turkey
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years of age or older
- Positive for hepatitis B surface antigen (HBsAg) for at least six months
- Citizen of the Republic of Türkiye
You will not qualify if you...
- There are no exclusion criteria in this study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Guven Hospital
Ankara, Turkey (Türkiye), 06850
Actively Recruiting
2
Dicle University, Faculty of Medicine
Diyarbakır, Turkey (Türkiye)
Actively Recruiting
Research Team
Y
Yaşar Bayındır, MD
CONTACT
M
Mustafa Kemal Çelen, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here